Tavin EM Tablet (Emtricitabine + Tenofovir Disoproxil Fumarate): Antiretroviral Tablet | For HIV-1 Infection Management, Pre-Exposure Prophylaxis (PrEP), and Viral Load Suppression

Tavin EM Tablet contains two antiretroviral medicines used together to manage HIV-1 infection and, in certain situations, help prevent it. It works by blocking an enzyme the virus needs to multiply, helping reduce viral activity in the body. For treatment, it is used alongside other HIV medicines, while preventive use requires specific medical guidance.

Tavin EM Tablet (Emtricitabine 200mg + Tenofovir Disoproxil Fumarate 300mg)

Package	QTY	Price	Add To Cart
30 Tablet/s		$70.00
60 Tablet/s		$140.00
90 Tablet/s		$210.00

Skip to the end of the images gallery

Skip to the beginning of the images gallery

Product Overview

Tavin EM Tablet contains two active ingredients, emtricitabine and tenofovir disoproxil fumarate, which work together to reduce the multiplication of HIV in the body. It is used with other medicines to manage HIV infection and may also be prescribed for HIV prevention (PrEP) in eligible individuals. By reducing viral activity, Tavin EM helps protect the immune system and supports long-term health when used correctly.

How Does Tavin EM Tablet Work? (Pharmacodynamics)

HIV needs to make copies of itself to spread through the body. Tavin EM interrupts this process using two medicines that belong to a group called nucleoside/nucleotide reverse transcriptase inhibitors (NRTIs).

Both ingredients block an enzyme called reverse transcriptase, which the virus needs to multiply. This helps lower the amount of virus in the body and limits further damage to the immune system.

Understanding Its Role in the Body

Tavin EM works differently depending on why it is prescribed.

For HIV treatment: It helps control viral activity when combined with other prescribed HIV medicines, supporting immune health.
For HIV prevention (PrEP): It helps reduce the risk of acquiring HIV when taken consistently as part of a recommended prevention plan.

Tavin EM does not cure HIV. Regular dosing, appropriate testing, and medical follow-ups are essential for effective treatment or prevention.

Expected Results

When used for HIV treatment, viral levels may begin decreasing within the first few weeks. Achieving sustained viral suppression can take several months, depending on the complete treatment plan and individual response.

For PrEP, protection builds with consistent use and varies according to the type of exposure. It is not immediate, and regular HIV testing remains necessary.

Pharmacokinetics: How the Body Processes It

After taking Tavin EM Tablet, the ingredients are absorbed through the digestive system and enter the bloodstream.

Absorption: Emtricitabine and tenofovir are absorbed into the body, where they become active inside cells.
Processing: Tenofovir disoproxil fumarate is converted into tenofovir, while emtricitabine undergoes very little breakdown in the body.
Elimination: Both ingredients are mainly removed through the kidneys.

Their active forms remain inside cells for longer, helping maintain their effects when the medicine is taken regularly.

Clinical Considerations

Kidney health: Tenofovir may affect kidney function, so kidney tests may be needed before and during treatment.
Bone health: Long-term use may reduce bone mineral density in some individuals.
Hepatitis B: Stopping Tavin EM may cause hepatitis B to worsen in people who also have this infection. Do not discontinue it without medical advice.
Medicine interactions: Tell your healthcare professional about other medicines, particularly those that may affect kidney function.
HIV testing: When used for PrEP, confirm a negative HIV test before starting and complete regular testing during use.
Consistent dosing: Take the medicine as prescribed. Missing doses can reduce its effectiveness.

Storage Instructions

Store Tavin EM Tablets at room temperature, preferably 20°C to 25°C, unless the packaging specifies otherwise. Keep them in their original container, tightly closed and protected from moisture. Store out of reach of children.

Conclusion

Tavin EM Tablet combines emtricitabine and tenofovir disoproxil fumarate to help manage HIV or reduce the risk of acquiring it when prescribed for PrEP. Consistent use, regular testing, and medical guidance help ensure the treatment remains effective and appropriate for individual needs.

Precautions

Tavin EM Tablet (Emtricitabine + Tenofovir Disoproxil Fumarate) requires careful use because it may affect kidney function, bone health, and liver health in some people. Regular checkups, taking the medicine consistently, and discussing existing health conditions with your doctor can help reduce potential risks.

Before You Start

Consult your healthcare professional: Confirm whether Tavin EM is suitable for your condition and intended treatment.
Check kidney health: Inform your doctor about any kidney problems, as tenofovir may affect kidney function.
Discuss liver conditions: Mention any history of hepatitis B or other liver problems, as stopping this medicine may worsen hepatitis B.
Check bone health: Tell your doctor if you have osteoporosis or a history of frequent fractures.
Mention other medicines: Report all medicines and supplements you take, especially those that may affect the kidneys.
Pregnancy or breastfeeding: Discuss your treatment plan with your healthcare professional.

While Using It

Follow the prescribed schedule: Take Tavin EM regularly and avoid missing doses.
Attend routine tests: Your doctor may check kidney function, liver health, and bone health when needed.
Stay aware of unusual symptoms: Report persistent weakness, muscle discomfort, or changes in urination.
Avoid unnecessary medicines: Check with your doctor before taking frequent or high doses of pain relievers such as ibuprofen.
Do not stop suddenly: Speak with your doctor before stopping treatment, particularly if you have hepatitis B.

When to Seek Medical Help

Kidney concerns: Report reduced urination, unusual swelling, or persistent weakness.
Bone or muscle problems: Contact your doctor if you develop unexplained bone pain, muscle weakness, or difficulty walking.
Liver-related symptoms: Seek medical advice for yellowing of the skin or eyes, dark urine, or persistent abdominal pain.
Severe reactions: Seek urgent medical attention for rapid breathing, severe weakness, or an allergic reaction involving facial swelling or breathing difficulties.

Note:

Tavin EM Tablet should be used under medical supervision. Regular kidney monitoring and consistent dosing are important. If prescribed for HIV prevention, confirm your HIV-negative status before starting and follow the recommended testing schedule. Never change or stop treatment without medical advice.

Usage

Take it as prescribed: Tavin EM Tablet (Emtricitabine + Tenofovir Disoproxil Fumarate) is generally taken once daily. Follow the dose and schedule recommended by your healthcare professional.
Make it part of your routine: Swallow the tablet with water, with or without food. Taking it at the same time each day helps maintain consistent medicine levels in your body.
Avoid skipping doses: Regular use is important for effective treatment or prevention. Missing doses may reduce protection or make treatment less effective.
Missed a dose? Take it when you remember, unless your next dose is nearly due. Skip the missed dose if necessary, and never double your dose.
Check your kidney health: Your doctor may recommend kidney function tests before and during treatment, as tenofovir can sometimes affect the kidneys.
Discuss other medicines: Inform your doctor if you take medicines that may affect kidney function or interact with Tavin EM.
Keep up with regular check-ups: Follow the recommended testing schedule to monitor your health and ensure the medicine is working as intended.

Uses

Tavin EM Tablet contains Emtricitabine and Tenofovir Disoproxil Fumarate, two antiviral medicines that work together to interfere with viral multiplication in the body.

HIV-1 treatment: Used alongside other antiretroviral medicines to help control HIV-1 infection.
HIV-1 prevention (PrEP): May be prescribed to eligible HIV-negative individuals to reduce the risk of acquiring HIV-1 when used consistently with other preventive measures.
Reduces viral multiplication: Both ingredients help block an enzyme that the virus needs to make new copies of itself.
Supports long-term viral control: When combined with a complete treatment regimen, it helps reduce viral levels and supports immune health.

Note: Tavin EM is not a complete HIV treatment on its own and must be combined with other prescribed medicines when used for HIV-1 treatment. Before starting it for PrEP, an HIV-negative test result must be confirmed, with regular testing during use. Tell your doctor if you have hepatitis B, as stopping the medicine may cause a worsening of hepatitis B infection. Do not stop treatment without medical advice.

Side Effects

Tavin EM Tablet (Emtricitabine + Tenofovir Disoproxil Fumarate) may cause side effects as your body adjusts to the medicine. Some people may experience nausea, headache, or tiredness, especially during the first few weeks of treatment. Not everyone experiences side effects.

Common Side Effects

Nausea: You may feel sick or uncomfortable in your stomach.
Headache: Some people may experience mild or occasional headaches.
Diarrhea: You may notice loose stools or more frequent bowel movements.
Dizziness: You may feel lightheaded or slightly unsteady.
Tiredness: You may feel more tired or weak than usual.
Stomach discomfort: Mild abdominal pain, bloating, or digestive discomfort may occur.
Skin changes: Some people may notice mild skin rashes or darkening of the skin, particularly on the palms or soles.

Serious Side Effects

Kidney problems: Reduced urination, swelling in the legs, or unusual tiredness may indicate kidney problems and require prompt medical attention.
Liver problems: Yellowing of the skin or eyes, dark urine, or persistent abdominal pain may indicate liver trouble.
Bone problems: Long-term use may reduce bone mineral density, increasing the risk of bone weakness or fractures.
Lactic acidosis: Unusual muscle pain, severe weakness, rapid breathing, or persistent stomach discomfort may indicate a rare but serious condition.
Severe allergic reactions: Swelling of the face or throat, severe rash, or difficulty breathing requires emergency medical care.
Hepatitis B flare-up: People with hepatitis B may experience serious worsening of liver problems if the medicine is stopped.
Immune system changes: When used as part of HIV treatment, improvement in immune function may sometimes reveal symptoms of previously hidden infections.

Note: Regular kidney function tests and, when appropriate, liver and bone health monitoring may be recommended. Do not stop the medicine without medical advice, especially if you have hepatitis B. Seek medical attention if you experience severe or unusual symptoms.

FAQs

1. What is Tavin EM Tablet used for?

Tavin EM Tablet contains emtricitabine and tenofovir disoproxil fumarate. It is used with other medicines to manage HIV infection and may also be prescribed as PrEP to help prevent HIV infection.

2. How does Tavin EM Tablet work?

It blocks an enzyme that HIV needs to multiply in the body. This helps reduce the amount of virus and supports the immune system.

3. How should I take Tavin EM Tablet?

Take Tavin EM Tablet exactly as prescribed, usually once daily. Swallow it with water and try to take it at the same time each day.

4. Can Tavin EM Tablet be taken with or without food?

Yes, Tavin EM Tablet can generally be taken with or without food. Taking it with food may help if you experience stomach discomfort.

5. What are the common side effects of Tavin EM Tablet?

Some people may experience nausea, headache, diarrhoea, dizziness, or tiredness. These effects are often mild, but speak to your doctor if they continue.

6. Can Tavin EM Tablet affect kidney health?

Yes, tenofovir may affect kidney function in some people. Your doctor may recommend regular kidney tests to monitor your health during treatment.

7. Is Tavin EM Tablet enough to treat HIV on its own?

No. When used to treat HIV, Tavin EM Tablet must be combined with other prescribed HIV medicines to control the infection effectively.

8. What happens if I miss a dose of Tavin EM Tablet?

Take the missed dose when you remember, unless it is almost time for your next dose. Never take two doses together to make up for a missed one.

9. Can Tavin EM Tablet be used during pregnancy?

It may be prescribed during pregnancy when appropriate. Your doctor will assess the benefits and possible risks before recommending treatment.

10. Can I stop taking Tavin EM Tablet when I feel better?

No. Do not stop taking it without medical advice. Stopping treatment may allow HIV to multiply again, and people with hepatitis B may experience worsening liver problems after discontinuation.

Interactions

Tavin EM Tablets may interact with certain medicines, affecting how well the treatment works or increasing the risk of side effects. Some combinations can put extra strain on the kidneys or change how medicines are removed from the body. Understanding these interactions can help you use Tavin EM more safely.

1. Other Antiviral Medicines

Medicines containing tenofovir, emtricitabine, or lamivudine may lead to duplicate treatment or unwanted effects.
Avoid combining them unless specifically advised by your healthcare professional.

2. Painkillers (NSAIDs)

Painkillers such as ibuprofen, diclofenac, and naproxen may increase the risk of kidney problems, particularly when taken in high doses or frequently.
Ask your healthcare professional before using these medicines.

3. Certain Antibiotics

Antibiotics such as gentamicin and amikacin may increase the risk of kidney damage when used with Tavin EM.
Your healthcare professional may recommend kidney function tests.

4. Other Medicines That Affect the Kidneys

Medicines such as acyclovir, valacyclovir, and ganciclovir may increase kidney-related side effects or affect how the ingredients are cleared from the body.
These combinations may require closer monitoring.

5. Certain Hepatitis C Medicines

Some treatments containing sofosbuvir with ledipasvir or velpatasvir may increase tenofovir exposure.
Your healthcare professional may need to monitor kidney function, especially when other medicines are involved.

6. Certain HIV Medicines

Some HIV treatment combinations, particularly those containing ritonavir or cobicistat, may increase tenofovir levels and the risk of kidney-related side effects.
Your healthcare professional may adjust the treatment plan or recommend monitoring.

Tips to Avoid Interactions

Share a complete list of your medicines, supplements, and herbal products.
Avoid taking additional antiviral medicines without medical advice.
Check before using painkillers regularly.
Attend recommended kidney function tests and follow-up appointments.
Do not stop Tavin EM or change your dose without consulting your healthcare professional.

Note: Not every combination causes problems, but some medicines may increase kidney-related risks or affect treatment. Always check with your healthcare professional before starting or combining medicines.